Bluebird bio earnings
WebAug 9, 2024 · Bluebird Bio, Inc. (NASDAQ:NASDAQ:BLUE) Q2 2024 Earnings Conference Call August 9, 2024 8:00 AM ETCompany ParticipantsNick Leschly – Chief Executive OfficerElizabeth Pingpank – Direct... Webbluebird bio Inc. Annual stock financials by MarketWatch. View the latest BLUE financial statements, income statements and financial ratios.
Bluebird bio earnings
Did you know?
WebAug 4, 2024 · Bluebird Bio (BLUE) came out with a quarterly loss of $1.29 per share versus the Zacks Consensus Estimate of a loss of $1.31. This compares to loss of $3.58 per share a year ago. These figures are ... Webbluebird bio Pioneering Gene Therapies Recode for Life We're pursuing curative gene therapies to give patients and their families more bluebird days. Novel treatment option approved for CALD bluebird announces first FDA approved therapy for rare, neurodegenerative condition Read More We Persist for Patients
WebApr 3, 2024 · Bluebird bio Inc NASDAQ: BLUE Share price (2/10/23): $5.92 Market cap (2/10/23): $491 million 5 Bluebird bio Inc Expert Interviews, now on BamSEC. Powered by Tegus. See All BLUE Interviews Transcripts CY 2024 Other Revised 01/12/23 bluebird bio Inc at JPMorgan Healthcare Conference 01/12/23 CY 2024 Web1 day ago · Adds bluebird bio's reference in the analysis, adds name of Vertex and CRISPR Therapeutics' therapy. April 12 (Reuters) - Vertex Pharmaceuticals Inc VRTX.O and CRISPR Therapeutics AG's CRSP.BN one ...
WebApr 14, 2024 · With the market capitalization of bluebird bio Inc. currently standing at about $344.49 million, investors are eagerly awaiting this quarter’s results, scheduled for May 08, 2024 – May 12, 2024. As a result, investors might want to see an improvement in the … WebAug 21, 2024 · As for its balance sheet, the company had restricted cash, cash and cash equivalents and marketable securities balance of about $218 million, which included restricted cash of close to $45 million...
Web23 hours ago · Bluebird Bio signaled a delay in its sickle cell disease drug application to the FDA in its Q4 earnings release.
Web15 hours ago · Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy ... jared leto scott disick look alikeWebNov 8, 2024 · bluebird bio, Inc. BLUE reported an adjusted loss of 92 cents per share (excluding restructuring charges) from continued operations for the third quarter of 2024, narrower than the Zacks Consensus ... low folate cancerWeb1 day ago · U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 100 points on Thursday. Following the market opening Thursday, the … jared leto severed headWebApr 5, 2024 · bluebird bio GAAP EPS of -$0.38 misses by $0.18, revenue of $0.06M misses by $15.34M SA News Wed, Mar. 29 1 Comment Earnings history by period FQ3 … jared leto says it\u0027s morbin timeWebApr 10, 2024 · Bluebird Bio reports Q4 EPS (38c), consensus (44c) Reports Q4 revenue $.06M vs $1.6M last year. The Company’s cash and cash equivalents, marketable securities and restricted... 13d ago BLUE See More BLUE News > Financials Income Statment Balance Sheet Cash Flow Annual jared leto recent highlightsWebMar 4, 2024 · bluebird bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Operational Progress February 23, 2024 - … Results and Highlights Operational Progress 02/23/21 Earnings CAMBRIDGE, Mass. --(BUSINESS WIRE)- … low folate but not anaemicWebFeb 9, 2024 · Bluebird Bio (BLUE) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook ... low folate but not anemic